The CDC's Advisory Committee on Immunization Practices has identified the purposes of a COVID-19 vaccine as (1) decrease death and serious disease, (2) preserve functioning of society, (3) reduce extra burden that COVID-19 is having on people already facing disparities and (4) increase the chance for everyone to enjoy health and well-being.
The vaccine is made available based on ethical principles of maximizing benefits, minimizing harm, striving for equity, justice and fairness, and making transparent decisions. Ethical considerations include prioritizing Missourians who have been disproportionally impacted by the COVID-19 pandemic. Missouri’s Advisory Committee for Equitable COVID-19 Vaccine Distribution meets weekly and includes a growing list of partners.
COVID-19 vaccines are open to anyone age 12 and up, regardless of residency, and are distributed to more locations throughout the state as availability increases.
Two of the vaccines require two doses that are administered at least 21 days apart. It is important patients return for the second dose (ideally to the same provider of the first dose) to develop the highest level of immunity.
Safety is incorporated into every level of a vaccine’s development cycle. Clinical trials are an important part of determining vaccine safety and efficacy. Currently, Pfizer, Moderna and Janssen have completed phase 3 clinical trials involving tens thousands of participants. The trials determined the safety and efficacy of the vaccines in thousands of participants. The purpose of clinical trials is to generate scientific data and other information for the Food and Drug Administration to review and base their recommendations on. Today, millions of Americans have received both doses of the Pfizer and Moderna mRNA vaccines.
The safety and efficacy data has also been reviewed by an independent expert committee called the Advisory Committee on Immunization Practices (ACIP), which also recommended the vaccines for emergency use. Pfizer’s clinical trial enrolled 44,000+ participants with 42% globally having racially and ethnically diverse backgrounds. Of Moderna’s 30,000 trial participants, 37% were from minority communities, including 6,000 Hispanic and 3,000 Black participants. Janssen’s trial included 43,783 participants in the United States, Latin America and South Africa. AstraZeneca’s initial trial data included participants from Brazil and the United Kingdom while the company continues to conduct trials in South Africa, Kenya, Latin America, Japan, Russia and the United States.learn more watch video
We are committed to providing a free COVID-19 vaccination experience to anyone, regardless of where they are from or if they have insurance. No person can be billed for the COVID-19 vaccine. Vaccination providers may charge an administration fee to insurance, Medicaid or Medicare, if applicable in your situation. Uninsured Missourians will be able to receive the vaccination regardless of their health insurance status.
COVID-19 vaccines are lifesaving developments. Vaccinations have saved hundreds of millions of lives over the last century. Scientists have developed vaccines for Smallpox, Polio, Measles, Mumps, Rubella, Hepatitis, Meningitis and more. Data from clinical trials indicate:
- 95% efficacy rate for Pfizer’s vaccine
- 94.5% efficacy rate for Moderna’s vaccine
- 85% efficacy rate (for preventing severe disease) for Janssen's vaccine
- 90% efficacy rate for AstraZeneca’s vaccine (not yet authorized for emergency use in U.S.)
There are two primary tools in Missouri to find a vaccine close to you.